The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
Open accessAbstract
Uric acid (UA) is synthesized mainly in the liver, intestines, and vascular endothelium as the end product of an exogenous purine from food and endogenously from damaged, dying, and dead cells. The kidney plays a dominant role in UA excretion, and the kidney excretes approximately 70% of daily produced UA; the remaining 30% of UA is excreted from the intestine. When UA production exceeds UA excretion, hyperuricemia occurs. Hyperuricemia is significantly associated with the development and severity of the metabolic syndrome. The increased urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) expression, and glycolytic disturbances due to insulin resistance may be associated with the development of hyperuricemia in metabolic syndrome. Hyperuricemia was previously thought to be simply the cause of gout and gouty arthritis. Further, the hyperuricemia observed in patients with renal diseases was considered to be caused by UA underexcretion due to renal failure, and was not considered as an aggressive treatment target. The evidences obtained by basic science suggests a pathogenic role of hyperuricemia in the development of chronic kidney disease (CKD) and cardiovascular diseases (CVD), by inducing inflammation, endothelial dysfunction, proliferation of vascular smooth muscle cells, and activation of the renin-angiotensin system. Further, clinical evidences suggest that hyperuricemia is associated with the development of CVD and CKD. Further, accumulated data suggested that the UA-lowering treatments slower the progression of such diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 885
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Vitart, V., Rudan, I., Hayward, C., Gray, N. K., Floyd, J., Palmer, C. N., Knott, S. A., Kolcic, I., Polasek, O., Graessler, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.106 · Cited by 799
Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
Grayson, P. C., Kim, S. Y., LaValley, M., & Choi, H. K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20344 · Cited by 756
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Ichida, K., Matsuo, H., Takada, T., Nakayama, A., Murakami, K., Shimizu, T., Yamanashi, Y., Kasuga, H., Nakashima, H., Nakamura, T., et al. (2012) · Nature Communications · doi:10.1038/ncomms1756 · Cited by 701
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis
Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20065 · Cited by 671
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Association Between Serum Uric Acid and Development of Type 2 Diabetes
Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., Saito, A., & Sone, H. (2009) · Diabetes Care · doi:10.2337/dc09-0288 · Cited by 549
Physiological functions and pathogenic potential of uric acid: A review
El Ridi, R., & Tallima, H. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.03.003 · Cited by 542
Hyperuricemia and risk of stroke: A systematic review and meta‐analysis
Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24612 · Cited by 484
Matsuo, H., Takada, T., Ichida, K., Nakamura, T., Nakayama, A., Ikebuchi, Y., Ito, K., Kusanagi, Y., Chiba, T., Tadokoro, S., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000237 · Cited by 437
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
SLC2A9 Is a High-Capacity Urate Transporter in Humans
Caulfield, M. J., Munroe, P. B., O'Neill, D., Witkowska, K., Charchar, F. J., Doblado, M., Evans, S., Eyheramendy, S., Onipinla, A., Howard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050197 · Cited by 378
Li, L., Yang, C., Zhao, Y., Zeng, X., Liu, F., & Fu, P. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-122 · Cited by 371
Lv, Q., Meng, X.-F., He, F.-F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X.-J., Liu, J.-S., Zhu, Z.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056864 · Cited by 364
Metabolic effects of dietary fructose
Hallfrisch, J. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.9.2189777 · Cited by 357
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Yu, W., & Cheng, J.-D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582680 · Cited by 344
Wang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114259 · Cited by 341
Zhao, Y., Xu, L., Tian, D., Xia, P., Zheng, H., Wang, L., & Chen, L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13101 · Cited by 333
The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts
Li, S., Sanna, S., Maschio, A., Busonero, F., Usala, G., Mulas, A., Lai, S., Dei, M., Orrù, M., Albai, G., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030194 · Cited by 310
Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E., Macias, N., Santos, A., Pérez de Jose, A., Cedeño, S., Linares, T., & Luño, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.016 · Cited by 302
Yuan, H., Yu, C., Li, X., Sun, L., Zhu, X., Zhao, C., Zhang, Z., & Yang, Z. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2527 · Cited by 266
Li, M., Hu, X., Fan, Y., Li, K., Zhang, X., Hou, W., & Tang, Z. (2016) · Scientific Reports · doi:10.1038/srep19520 · Cited by 257
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output
Perez‐Ruiz, F., Calabozo, M., Erauskin, G. G., Ruibal, A., & Herrero‐Beites, A. M. (2002) · Arthritis Care & Research · doi:10.1002/art.10792 · Cited by 250
Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Peluso, I., Morabito, G., Urban, L., Ioannone, F., & Serafi, M. (2012) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/187153012803832602 · Cited by 236
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G. (2003) · Circulation · doi:10.1161/01.cir.0000046448.26751.58 · Cited by 225
Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies
Li, M., Hou, W., Zhang, X., Hu, L., & Tang, Z. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.051 · Cited by 222
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Bose, B., Badve, S. V., Hiremath, S. S., Boudville, N., Brown, F. G., Cass, A., de Zoysa, J. R., Fassett, R. G., Faull, R., Harris, D. C., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft378 · Cited by 222
Sumino, H., Ichikawa, S., Kanda, T., Nakamura, T., & Sakamaki, T. (1999) · The Lancet · doi:10.1016/s0140-6736(99)92381-4 · Cited by 221
Role of the intestinal tract in the elimination of uric acid
Sorensen, L. B. (1965) · Arthritis & Rheumatism · doi:10.1002/art.1780080429 · Cited by 221
Kelishadi, R., Mansourian, M., & Heidari-Beni, M. (2014) · Nutrition · doi:10.1016/j.nut.2013.08.014 · Cited by 199
Bredemeier, M., Lopes, L. M., Eisenreich, M. A., Hickmann, S., Bongiorno, G. K., d’Avila, R., Morsch, A. L. B., da Silva Stein, F., & Campos, G. G. D. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0757-9 · Cited by 188
Uric acid and the cardio‐renal effects of SGLT2 inhibitors
Bailey, C. J. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13670 · Cited by 183
Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
Nomura, J., Busso, N., Ives, A., Matsui, C., Tsujimoto, S., Shirakura, T., Tamura, M., Kobayashi, T., So, A., & Yamanaka, Y. (2014) · Scientific Reports · doi:10.1038/srep04554 · Cited by 181
The genetic basis of hyperuricaemia and gout
Merriman, T. R., & Dalbeth, N. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.02.027 · Cited by 180
Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies
Zuo, T., Liu, X., Jiang, L., Mao, S., Yin, X., & Guo, L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0379-z · Cited by 178
Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association
Mallat, S. G., Al Kattar, S., Tanios, B. Y., & Jurjus, A. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0684-z · Cited by 175
Recent advances on uric acid transporters
Xu, L., Shi, Y., Zhuang, S., & Liu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.20135 · Cited by 175
Kanji, T., Gandhi, M., Clase, C. M., & Yang, R. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0047-z · Cited by 174
Zhu, P., Liu, Y., Han, L., Xu, G., & Ran, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100801 · Cited by 159
Sattui, S. E., & Gaffo, A. (2016) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x16646703 · Cited by 157
Close correlation between visceral fat accumulation and uric acid metabolism in healthy men
Takahashi, S., Yamamoto, T., Tsutsumi, Z., Moriwaki, Y., Yamakita, J.-I., & Higashino, K. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90210-9 · Cited by 155
Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review.
Li, R., Yu, K., & Li, C. (2019) · PubMed · doi:10.6133/apjcn.201811_27(6).0022 · Cited by 153
Hosoya, T., Ohno, I., Nomura, S., Hisatome, I., Uchida, S., Fujimori, S., Yamamoto, T., & Hara, S. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-0935-8 · Cited by 151
Berger, L., & Yű, T.-F. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90222-3 · Cited by 148
Patetsios, P., Song, M., Shutze, W. P., Pappas, C., Rodino, W., Ramirez, J. A., & Panetta, T. F. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01621-6 · Cited by 143
Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways.
den Berghe, G. V. (1986) · PubMed · Cited by 136
Uric Acid and the Origins of Hypertension
Feig, D. I., Madero, M., Jalal, D. I., Sánchez‐Lozada, L. G., & Johnson, R. J. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.12.078 · Cited by 135
Jamnik, J., Rehman, S., Mejía, S. B., de Souza, R. J., Khan, T. A., Leiter, L. A., Wolever, T. M. S., Kendall, C. W. C., Jenkins, D. J. A., & Sievenpiper, J. L. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013191 · Cited by 134
Uric acid: bystander or culprit in hypertension and progressive renal disease?
Mené, P., & Punzo, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830e4945 · Cited by 131
ter Horst, K. W., Schene, M. R., Holman, R., Romijn, J. A., & Serlie, M. J. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137786 · Cited by 126
Whelton, A., MacDonald, P. A., Zhao, L., Hunt, B., & Gunawardhana, L. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318204aab4 · Cited by 123
The Effect of Female Hormones Upon Urate Transport Systems in the Mouse Kidney
Takiue, Y., Hosoyamada, M., Kimura, M., & Saito, H. (2011) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2010.551645 · Cited by 120
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Taniguchi, T., Ashizawa, N., Matsumoto, K., Saito, R., Motoki, K., Sakai, M., Chikamatsu, N., Hagihara, C., Hashiba, M., & Iwanaga, T. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259341 · Cited by 105
Jia, Z., Zhang, X., Kang, S., & Wu, Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.026 · Cited by 99
Zhang, T., & Pope, J. E. (2017) · Rheumatology · doi:10.1093/rheumatology/kex065 · Cited by 97
Schröder, K., Vecchione, C., Jung, O., Schreiber, J. G., Shiri‐Sverdlov, R., van Gorp, P. J., Busse, R., & Brandes, R. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.026 · Cited by 93
Reinders, M. K., van Roon, E. N., Houtman, P. M., Brouwers, J. R. B. J., & Jansen, T. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0528-3 · Cited by 89
The glycolytic pathway to coronary heart disease: A hypothesis
Leyva, F., Wingrove, C. S., Godsland, I. F., & Stevenson, J. C. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90026-9 · Cited by 85
Shibagaki, Y., Ohno, I., Hosoya, T., & Kimura, K. (2014) · Hypertension Research · doi:10.1038/hr.2014.107 · Cited by 83
Chou, H., Chiu, H.-T., Tsai, C.-W., Ting, I., Yeh, H., Huang, H.-C., & Kuo, C. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx313 · Cited by 83
Effect of sex hormones on lipid peroxidation in rat liver
Huh, K. Y., Shin, U.-S., Choi, J., & Lee, S. (1994) · Archives of Pharmacal Research · doi:10.1007/bf02974233 · Cited by 79
Yisireyili, M., Hayashi, M., Wu, H., Uchida, Y., Yamamoto, K., Kikuchi, R., Hamrah, M. S., Nakayama, T., Cheng, X. W., Matsushita, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01366-3 · Cited by 74
Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1
Uetake, D., Ohno, I., Ichida, K., Yamaguchi, Y., Saikawa, H., Endou, H., & Hosoya, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2597 · Cited by 73
Dalbeth, N., House, M. E., Gamble, G. D., Horne, A. M., Pool, B., Purvis, L., Stewart, A., Merriman, M. E., Cadzow, M. J., Phipps‐Green, A. J., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202732 · Cited by 73
Derosa, G., Maffioli, P., & Sahebkar, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.012 · Cited by 72
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
Dalbeth, N., & Merriman, T. R. (2008) · Rheumatology · doi:10.1093/rheumatology/ken460 · Cited by 67
Alem, M. M. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12432 · Cited by 60
Xin, Y., Guo, Y., Li, Y., Ma, Y., Li, L., & Jiang, H. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.11.013 · Cited by 58
Gao, L., Wang, B., Pan, Y. H., Lü, Y., & Cheng, R. (2021) · Clinical Cardiology · doi:10.1002/clc.23643 · Cited by 56
Effects of Allopurinol on Endothelial Dysfunction: A Meta-Analysis
Kanbay, M., Siriopol, D. C., Nistor, I., Elçioğlu, Ö. C., Telci, Ö., Takır, M., Johnson, R. J., & Covic, A. C. (2014) · American Journal of Nephrology · doi:10.1159/000360609 · Cited by 55
Bach, M., & Simkin, P. A. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000035 · Cited by 55
Cicero, A. F. G., Pirro, M., Watts, G. F., Mikhailidis, D. P., Banach, M., & Sahebkar, A. (2017) · Drugs · doi:10.1007/s40265-017-0839-5 · Cited by 52
Chen, S., Yang, H., Chen, Y., Wang, J., Xu, L., Miao, M., & Xu, C. (2020) · Medicine · doi:10.1097/md.0000000000019088 · Cited by 50
Zhao, L., Cao, L., Zhao, T., Yang, X., Zhu, X., Zou, H., Wan, W., & Xue, Y. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000682 · Cited by 48
Yu, H., Liu, X., Song, Y., Cheng, J., Bao, H. F., Qin, L., Zhou, X., Wang, L., & Peng, A. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1586-y · Cited by 47
Xin, W., Mi, S., & Lin, Z. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12215 · Cited by 45
Meta-analysis of the correlation between serum uric acid level and carotid intima-media thickness
Ma, M., Wang, L., Huang, W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246416 · Cited by 42
Daniali, S. S., Kelishadi, R., Goli, P., Riahi, R., & Pourmirzaei, M. (2020) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_733_19 · Cited by 41
Febuxostat and Cardiovascular Events: A Systematic Review and Meta-Analysis
Cuenca, J. A., Balda, J., Palacio, A., Young, L., Pillinger, M. H., & Tamariz, L. J. (2019) · International Journal of Rheumatology · doi:10.1155/2019/1076189 · Cited by 40
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
Yanai, H., Hakoshima, M., Adachi, H., & Katsuyama, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094416 · Cited by 34
Self-citationEfficacy of Benzbromarone in Hyperuricemic Patients Associated with Chronic Kidney Disease
Fujimori, S., Ooyama, K., Ooyama, H., & Moromizato, H. (2011) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2011.622732 · Cited by 31
Yanai, H., Hakoshima, M., Adachi, H., Kawaguchi, A., Waragai, Y., Harigae, T., Masui, Y., Kakuta, K., Hamasaki, H., Katsuyama, H., et al. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3046w · Cited by 31
Self-citationNg, H., Lee, Y., Kuo, W., Huang, P., Lee, W., & Lee, C. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000495814 · Cited by 28
Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population
Fan, Y. B., Wei, F., Lang, Y., & Wang, S. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000478 · Cited by 23
Impact of fenofibrate therapy on serum uric acid concentrations: a review and meta-analysis
Zhang, J., Ji, X., Dong, Z., Lü, J., Zhao, Y., Li, R., Li, C., & Chen, Y. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0808 · Cited by 21
Nishizawa, T., Taniura, T., & Nomura, S. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000335 · Cited by 20
Effects of Febuxostat on Mortality and Cardiovascular Outcomes
Al‐Abdouh, A., Khan, S. U., Barbarawi, M., Upadhrasta, S., Munira, S., Bizanti, A., Elias, H., Jat, A., Zhao, D., & Michos, E. D. (2020) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.04.012 · Cited by 16
Singh, T. P., Skalina, T., Nour, D., Murali, A., Morrison, S., Moxon, J. V., & Golledge, J. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0881-6 · Cited by 15
Barrientos-Regala, M. A., Macabeo, R., Ramirez-Ragasa, R., Pestaño, N. S., Punzalan, F. E. R., Tumanan-Mendoza, B. A., & Castillo, R. R. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000871 · Cited by 15
Cited by
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Chen, Y.-R., Lin, S.-B., Lv, J.-Y., Wu, Y., & Feng, W.-R. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124865 · Cited by 25
Metadata
- Authors
- Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-08-26
- Volume
- 22
- Issue
- 17
- Pages
- 9221
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3194570688
- Cited by
- 595
- References
- 98
- FWCI
- 41.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.